Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 11/2018

01-11-2018 | Letter to the Editor

Severe anemia after trans-catheter arterial chemoembolization—an unusual presentation of hemoglobin Zurich

Authors: Tanja Böhme, Michael Medinger, Claudia Suenderhauf, Oliver Speer, Markus Schmugge, Jakob Passweg, Adrian Bachofner

Published in: Annals of Hematology | Issue 11/2018

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Hitzig WH, Frick PG, Betke K, Huisman TH (1960) Hemoglobin Zurich: a new hemoglobin anomaly with sulfonamide-induced inclusion body anemia. Helv Paediatr Acta 15:499–514PubMed
2.
Frick PG, Hitzig H, Betke K (1962) Hemoglobin Zurich: I. A new hemoglobin anomaly associated with acute hemolytic episodes with inclusion bodies after sulfonamide therapy. J Hematol 20:261–271
3.
Zinkham WH, Vangrov JS, Dixon SM, Hutchison JL (1979) Observations on the rate and mechanism of hemolysis in individuals with Hb Zurich [His E7(63) β → Arg]: I. Concentrations of haptoglobin and hemopexin in the serum. John Hopkins Med J 144:37–40
4.
Milner PF, Wrightstone RN (1981) The unstable hemoglobins: a review: the function of red blood cells. Erythrocyte Pathobiol 51:197–222
5.
Bernard E, Schmid ER, Schmidlin D, Schaffner A, Germann R (2000) Hemoglobin Zurich and cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14:705–706CrossRef
6.
Dickerman JD, Holtzman NA, Zinkham WH (1973) Hemoglobin Zurich. A third family presenting with hemolytic reactions to sulfonamides. Am J Med 55:638–642CrossRef
Metadata
Title
Severe anemia after trans-catheter arterial chemoembolization—an unusual presentation of hemoglobin Zurich
Authors
Tanja Böhme
Michael Medinger
Claudia Suenderhauf
Oliver Speer
Markus Schmugge
Jakob Passweg
Adrian Bachofner
Publication date
01-11-2018
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 11/2018
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3353-2

Other articles of this Issue 11/2018

Annals of Hematology 11/2018 Go to the issue

Original Article

Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy

Original Article

Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis

Original Article

Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network

Original Article

The co-occurrence of driver mutations in chronic myeloproliferative neoplasms

Original Article

Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

Original Article

In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits